| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Qualigen Therapeutics, Inc. | President/CSO, Director | Common Stock | 34,500 | $19,665 | $0.5700 | 14 Jun 2022 | Direct |
| Qualigen Therapeutics, Inc. | President/CSO, Director | Stock Option (Right to Buy) | 130,000 | 11 Jul 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| QLGN | Qualigen Therapeutics, Inc. | 11 Jul 2022 | 1 | $0 | 4 | President/CSO, Director | 04 Aug 2022, 16:16 |
| QLGN | Qualigen Therapeutics, Inc. | 14 Jun 2022 | 1 | +$18,600 | 4 | President/CSO, Director | 15 Jun 2022, 16:05 |
| QLGN | Qualigen Therapeutics, Inc. | 08 Dec 2021 | 1 | $0 | 4 | President/ChiefStrategyOfficer, Director | 10 Dec 2021, 05:15 |